BRIEF-Madrigal Pharmaceuticals Qtrly Loss Per Share $0.67
March 13, 2018 at 07:13 AM EDT
* MADRIGAL PHARMACEUTICALS REPORTS 2017 FOURTH QUARTER AND YEAR-END FINANCIAL RESULTS, REVIEWS KEY CORPORATE ACHIEVEMENTS AND PROVIDES CLINICAL UPDATE ON MGL-3196
